To hear about similar clinical trials, please enter your email below
Trial Title:
The Internal Prospective Validation of the Cancer Admission Score (CAS) Prediction Model
NCT ID:
NCT06558487
Condition:
Oncology
Conditions: Official terms:
Neoplasms
Conditions: Keywords:
cancer care
emergency care
prediction model
admission
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Other
Intervention name:
Cancer Admission Score Prediction Model
Description:
A prediction model that calculates the chance for a patient to be admitted after triage
and after first blood results
Arm group label:
Cancer patients
Summary:
The goal of this single center prospective observational study is to determine the
agreement between the cancer admission score (CAS) predicted disposition and the actual
disposition in patients with an active cancer diagnosis visiting the emergency department
(ED). The main question it aims to answer are: Is the performance of the CAS good enough
to play a potential role in the ED care process. For each participant the CAS will be
calculated and compared to the actual outcome.
Detailed description:
The goal of this single center prospective observational study is to determine the
agreement between the cancer admission score (CAS) predicted disposition and the actual
disposition in patients with an active cancer diagnosis visiting the emergency department
(ED). The main question it aims to answer are: Is the performance of the CAS good enough
to play a potential role in the ED care process.
The first part of this study is an observational part. For patients with cancer that are
presented to the emergency department (ED) the cancer admission score (CAS) will be
calculated by the model both after triage and after the first blood results are in.
Furthermore, the expected disposition will be asked to the attending nurse after triage
and after the first blood results. Finally, the actual disposition will be written down
after the patient has left the ED, in combination with ED length of stay (LOS) and the
time for the attending physician to reach a decision about the disposition
(time-to-disposition) and the time for a patient to leave the ED (time-to-leave).
The second part is the interventional part. In this part we introduce an early bed
reservation intervention. The CAS is still calculated for the patient. If the CAS is 80%
or higher based on the triage, the attending physician will be alerted and a call to the
bed coordinator will be placed to reserve a bed in advance. After the first blood results
are known the second CAS will be calculated, if this drops below 70% the reserved bed can
be canceled by the attending physician. Similar to the first part, the expected
disposition from the attending nurse after triage and after first blood results will be
collected. Finally, the actual disposition, ED LOS, time-to-disposition and time-to-leave
will be noted.
Criteria for eligibility:
Study pop:
All adult patients with an active cancer diagnosis who visit the ED of the Erasmus
University Medical Center (Erasmus MC).
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Patients with solid or hematological malignancies and receiving systemic therapy or
having received systemic therapy within the last 3 months.
- Presented at or admitted from the emergency department for the oncology, hematology
neuro- or lung-oncology clinical unit.
Exclusion Criteria:
- <18 years old
- Only received a surgical intervention as cancer treatment
- Admitted to the ED for the surgical department
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Start date:
November 26, 2024
Completion date:
February 1, 2025
Lead sponsor:
Agency:
Erasmus Medical Center
Agency class:
Other
Source:
Erasmus Medical Center
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06558487
